New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review.

Physiotherapy Psoriatic arthritis Rehabilitation Treatment

Journal

Rheumatology and therapy
ISSN: 2198-6576
Titre abrégé: Rheumatol Ther
Pays: England
ID NLM: 101674543

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 24 12 2020
accepted: 03 03 2021
pubmed: 13 3 2021
medline: 13 3 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

Psoriatic arthritis (PsA) is a complex, multiform and chronic inflammatory disease characterized by the association of psoriasis and arthritis with other musculoskeletal and extra-articular manifestations. The treatment of PsA is rapidly evolving due to the introduction of new biologic and small-molecule drugs, and the aim of treatment is to induce a condition of remission or low disease activity in all disease domains. However, unmet treatment needs still persist for those patients with impaired function, reduced quality of life or comorbidities. In this context, physical therapy and rehabilitation could provide additional benefits by reducing disease activity and improving function. Although a large number of studies have assessed the role of physical therapy and exercise in other forms of chronic inflammatory arthritis, such as axial spondyloarthritis and rheumatoid arthritis, evidence on their effect on persons with PsA is still lacking. However, some studies have reported the potential positive role of physical therapy on the different disease domains of PsA, in helping to improve disease activity, prevent or improve articular impairment, improve pain management and improve quality of life. Here, we review current evidence on physical therapy, exercise and rehabilitation in patients with PsA. In particular, we review the literature focusing on each domain, to provide evidence of efficacy and effectiveness of exercise and rehabilitation on skin, peripheral arthritis, axial involvement, dactylitis, enthesitis and comorbidities.

Identifiants

pubmed: 33710586
doi: 10.1007/s40744-021-00298-9
pii: 10.1007/s40744-021-00298-9
pmc: PMC8217348
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

639-649

Références

Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957–70. https://doi.org/10.1056/NEJMra1505557 .
doi: 10.1056/NEJMra1505557 pubmed: 28273019
Lubrano E, Scriffignano S, Perrotta FM. Multimorbidity and comorbidity in psoriatic arthritis—a perspective. Expert Rev ClinImmunol. 2020. https://doi.org/10.1080/1744666X.2021.1825941 .
doi: 10.1080/1744666X.2021.1825941
Lubrano E, Perrotta FM, Scriffignano S, Coates LC, Helliwell P. Sustained very low disease activity and remission in psoriatic arthritis patients. Rheumatol Ther. 2019;6(4):521–8. https://doi.org/10.1007/s40744-019-00171-w .
doi: 10.1007/s40744-019-00171-w pubmed: 31428989 pmcid: 6858418
Smolen JS, Schöls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77(1):3–17. https://doi.org/10.1136/annrheumdis-2017-211734 .
doi: 10.1136/annrheumdis-2017-211734 pubmed: 28684559
Toussi A, Maverakis N, Le ST, Sarkar S, Raychaudhuri SK, Raychaudhuri SP. Updated therapies for the management of psoriatic arthritis. ClinImmunol. 2020;220:108536. https://doi.org/10.1016/j.clim.2020.108536 .
doi: 10.1016/j.clim.2020.108536
Lubrano E, Parsons WJ, Perrotta FM. Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors. J Rheumatol. 2016;43(5):918–23. https://doi.org/10.3899/jrheum.151404 .
doi: 10.3899/jrheum.151404 pubmed: 26980581
Perrotta FM, Marchesoni A, Lubrano E. Minimal disease activity and remission in psoriatic arthritis patients treated with anti-TNF-α drugs. J Rheumatol. 2016;43(2):350–5.
doi: 10.3899/jrheum.150805
Hagège B, Tan E, Gayraud M, Fautrel B, Gossec L, Mitrovic S. Remission and low disease activity in psoriatic arthritis publications: a systematic literature review with meta-analysis. Rheumatology. 2020;59(8):1818–25. https://doi.org/10.1093/rheumatology/keaa030 .
doi: 10.1093/rheumatology/keaa030 pubmed: 32118267
Mease PJ, Lertratanakul A, Anderson JK, et al. Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2. Ann Rheum Dis. 2020. https://doi.org/10.1136/annrheumdis-2020-218870 .
doi: 10.1136/annrheumdis-2020-218870 pubmed: 33272960
Lubrano E, Scriffignano S, Perrotta FM. Residual disease activity and associated factors in psoriatic arthritis. J Rheumatol. 2020;47(10):1490–5.
doi: 10.3899/jrheum.190679
Orbai AM, de Wit M, Mease PJ, et al. Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol. 2017;44:1522–8.
doi: 10.3899/jrheum.160904
Gasparyan AY, Ayvazyan L, Blackmore H, et al. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31:1409–17.
doi: 10.1007/s00296-011-1999-3
Paroutoglou K, Papadavid E, Christodoulatos GS, Dalamaga M. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations. Curr Obes Rep. 2020;9(3):165–78.
doi: 10.1007/s13679-020-00380-3
Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005;141(12):1580–4.
doi: 10.1001/archderm.141.12.1580
Stewart TJ, Tong W, Whitfeld MJ. The associations between psychological stress and psoriasis: a systematic review. Int J Dermatol. 2018;57(11):1275–82.
doi: 10.1111/ijd.13956
Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018;57(10):1165–72.
doi: 10.1111/ijd.14032
Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol. 2009;34(2):140–4.
doi: 10.1111/j.1365-2230.2008.02791.x
Alotaibi HA. Effects of weight loss on psoriasis: a review of clinical trials. Cureus. 2018;10(10):e3491.
pubmed: 30648033 pmcid: 6318144
Ko SH, Chi CC, Yeh ML, Wang SH, Tsai YS, Hsu MY. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019;7(7):CD011972. https://doi.org/10.1002/14651858.CD011972.pub2 .
doi: 10.1002/14651858.CD011972.pub2 pubmed: 31309536
Naldi L, Conti A, Cazzaniga S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014;170(3):634–42. https://doi.org/10.1111/bjd.12735 .
doi: 10.1111/bjd.12735 pubmed: 24641585
Li YF, Jiang LJ, Tao Y, Qin GL, Li Z, He W. The effects of walking exercise combined with continuous health education on prevention of psoriasis recurrence. J Nurs Adm. 2015;15(4):294–6.
Mahmood F, Coates LC, Helliwell PS. Current concepts and unmet needs in psoriatic arthritis. Clin Rheumatol. 2018;37(2):297–305.
doi: 10.1007/s10067-017-3908-y
Kavuncu V, Evcik D. Physiotherapy in rheumatoid arthritis. Med Gen Med. 2004;6(2):3.
Rausch Osthoff AK, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77(9):1251–60. https://doi.org/10.1136/annrheumdis-2018-213585 .
doi: 10.1136/annrheumdis-2018-213585 pubmed: 29997112
Canadian Spondylitis Association. https://spondylitis.ca/wp-content/uploads/2018/10/2018-PSA .
Sveaas SH, Smedslund G, Hagen KB, et al. Effect of cardiorespiratory and strength exercises on disease activity in patients with inflammatory rheumatic diseases: a systematic review and meta-analysis. Br J Sports Med. 2017;51:1065–72.
doi: 10.1136/bjsports-2016-097149
Lubrano E, Spadaro A, Parsons WJ, Atteno M, Ferrara N. Rehabilitation in psoriatic arthritis. J Rheumatol Suppl. 2009;83:81–2.
doi: 10.3899/jrheum.09235
Thomsen RS, Nilsen TIL, Haugeberg G, Bye A, Kavanaugh A, Hoff M. Impact of high-intensity interval training on disease activity and disease in patients with psoriatic arthritis: a randomized controlled trial. Arthritis Care Res. 2019;71(4):530–7. https://doi.org/10.1002/acr.23614 .
doi: 10.1002/acr.23614
Roger-Silva D, Natour J, Moreira E, Jennings F. A resistance exercise program improves functional capacity of patients with psoriatic arthritis: a randomized controlled trial. Clin Rheumatol. 2018;37(2):389–95. https://doi.org/10.1007/s10067-017-3917-x .
doi: 10.1007/s10067-017-3917-x pubmed: 29185133
Lindqvist M, Gard G. Hydrotherapy treatment for patients with psoriatic arthritis—a qualitative study. Open J TherRehabil. 2013;1:22–30. https://doi.org/10.4236/ojtr.2013.12005 .
doi: 10.4236/ojtr.2013.12005
Cozzi F, Ciprian L, Carrara M, et al. Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review. Int J Biometeorol. 2018;62(12):2065–71. https://doi.org/10.1007/s00484-018-1618-z .
doi: 10.1007/s00484-018-1618-z pubmed: 30276474
Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363–71.
doi: 10.1038/s41584-018-0006-8
Helliwell PS. Axial disease in psoriatic arthritis. Rheumatology. 2020;59(6):1193–5.
doi: 10.1093/rheumatology/kez629
Perrotta FM, Musto A, Lubrano E. New insights in physical therapy and rehabilitation in axial spondyloarthritis: a review. Rheumatol Ther. 2019;6(4):479–86. https://doi.org/10.1007/s40744-019-00170-x .
doi: 10.1007/s40744-019-00170-x pubmed: 31410786 pmcid: 6858478
Nash P. Therapies for axial disease in psoriatic arthritis. A systematic review. J Rheumatol. 2006;33:1431–4.
pubmed: 16724371
Millner JR, Barron JS, Beinke KM, et al. Exercise for ankylosing spondylitis: an evidence-based consensus statement. Semin Arthritis Rheum. 2016;45:411–27. https://doi.org/10.1016/j.semarthrit.2015.08.003 .
doi: 10.1016/j.semarthrit.2015.08.003 pubmed: 26493464
Regel A, Sepriano A, Baraliakos X, et al. Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open. 2017;3:e000397.
doi: 10.1136/rmdopen-2016-000397
Hilberdink B, van der Giesen F, Vliet Vlieland T, et al. Supervised group exercise in axial spondyloarthritis: patients’ satisfaction and perspective on evidence-based enhancements. Arthritis Care Res. 2019;1:1.
O’Dwyer T, O’Shea F, Wilson F. Exercise therapy for spondyloarthritis: a systematic review. Rheumatol Int. 2014;34:887–902.
doi: 10.1007/s00296-014-2965-7
Lubrano E, D’Angelo S, Parsons WJ, et al. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study. J Rheumatol. 2006;33:2029–34.
pubmed: 17014018
Lubrano E, Spadaro A, Amato G, et al. Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review. Semin Arthritis Rheum. 2015;44:542–50.
doi: 10.1016/j.semarthrit.2014.09.012
van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978–91.
doi: 10.1136/annrheumdis-2016-210770
Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum. 2018;48(1):35–43. https://doi.org/10.1016/j.semarthrit.2017.12.008 .
doi: 10.1016/j.semarthrit.2017.12.008 pubmed: 29429762
Gracey E, Burssens A, Cambré I, et al. Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis. Nat Rev Rheumatol. 2020;16(4):193–207. https://doi.org/10.1038/s41584-019-0364-x .
doi: 10.1038/s41584-019-0364-x pubmed: 32080619 pmcid: 7815340
Perrotta FM, Lories R, Lubrano E. To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis. RMD Open. 2021;7(1):e001480. https://doi.org/10.1136/rmdopen-2020-001480 .
Alfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998;26(3):360–6.
doi: 10.1177/03635465980260030301
Scott A, Huisman E, Khan K. Conservative treatment of chronic Achilles tendinopathy. CMAJ. 2011;183(10):1159–65.
doi: 10.1503/cmaj.101680
Mayer F, Hirschmuller A, Muller S, et al. Effects of short-term treatment strategies over 4 weeks in Achilles tendinopathy. Br J Sports Med. 2007;41:e6.
doi: 10.1136/bjsm.2006.031732
Petersen W, Welp R, Rosenbaum D. Chronic Achilles tendinopathy: a prospective randomized study comparing the therapeutic effect of eccentric training, the AirHeel brace, and a combination of both. Am J Sports Med. 2007;35:1659–67.
doi: 10.1177/0363546507303558
de Vos RJ, Weir A, Visser RJ, et al. The additional value of a night splint to eccentric exercises in chronic midportion Achilles tendinopathy: a randomised controlled trial. Br J Sports Med. 2007;41:e5.
doi: 10.1136/bjsm.2006.032532
Ordahan B, Türkoğlu G, Karahan AY, Akkurt HE. Extracorporeal shockwave therapy versus kinesiology taping in the management of plantar fasciitis: a randomized clinical trial. Arch Rheumatol. 2017;32(3):227–33.
doi: 10.5606/ArchRheumatol.2017.6059
Harjacek M, Kelava T, Lamot L. The therapeutic value of low-energy laser (LLLT) for enthesitis in children with juvenile spondyloarthropathies. Pediatr Rheumatol Online J. 2008;6(Suppl 1):P64–P64.
doi: 10.1186/1546-0096-6-S1-P64
Cosentino R, Falsetti P, Manca S, et al. Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. Ann Rheum Dis. 2001;60:1064–7.
doi: 10.1136/ard.60.11.1064
Aqil A, Siddiqui MR, Solan M, et al. Extracorporeal shock wave therapy is effective in treating chronic plantar fasciitis: a meta-analysis of RCTs. Clin Orthop Relat Res. 2013;471:3645–52.
doi: 10.1007/s11999-013-3132-2
ArmaganAlpturker K, Cerrahoglu ABL, Orguc IS. Evaluation effects of laser therapy and extracorporeal shock wave therapy with clinical parameters and magnetic resonance imaging for treatment of plantar fasciitis in patients with spondyloarthritis: a randomized controlled trial. Int J Rheumatol. 2020;2020:4386361.
Polachek A, Touma Z, Anderson M, et al. Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care Res. 2017;69(67):74.
Radner H, Lesperance T, Accortt NA, et al. Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis. Arthritis Care Res. 2017;69:1510–8.
doi: 10.1002/acr.23171
Thomsen RS, Nilsen TI, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M. Adiposity and physical activity as risk factors for developing psoriatic arthritis. Longitudinal data from the HUNT study. Arthritis Care Res (Hoboken). 2021;73(3):432–41. https://doi.org/10.1002/acr.24121 .
Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019;11(7):1652. https://doi.org/10.3390/nu11071652 .
doi: 10.3390/nu11071652 pmcid: 6683051
Konerman MA, Walden P, Joseph M, Jackson EA, Lok AS, Rubenfire M. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019;49(3):296–307.
doi: 10.1111/apt.15063
Klingberg E, Björkman S, Eliasson B, Larsson I, Bilberg A. Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up. Arthritis Res Ther. 2020;22(1):254.
doi: 10.1186/s13075-020-02350-5
Sukenik S, Baradin R, Codish S, et al. Balneotherapy at the Dead Sea area for patients with psoriatic arthritis and concomitant fibromyalgia. Isr Med Assoc J. 2001;3(2):147–50.
pubmed: 11344827

Auteurs

Fabio Massimo Perrotta (FM)

Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Campobasso, Italy.

Silvia Scriffignano (S)

Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Campobasso, Italy.

Devis Benfaremo (D)

Clinica Medica, Dipartimento Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.

Mario Ronga (M)

Orthopedics and Trauma Operative Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University Hospital G. Martino, University of Messina, Messina, Italy.

Michele Maria Luchetti (MM)

Clinica Medica, Dipartimento Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.

Ennio Lubrano (E)

Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Campobasso, Italy. enniolubrano@hotmail.com.

Classifications MeSH